Nov 11, 2023 at 2:25 PM#61
Saving this for reference. Top-tier content.
Last edited: Nov 11, 2023 at 3:25 PM
42 9TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 39 others
Reply Quote Save Share Report
Nov 11, 2023 at 2:42 PM#62
Slightly tangential to VERIFIED Vendor but Dr.LeslieOBGYN reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
28 11PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 25 others
Reply Quote Save Share Report
Nov 11, 2023 at 2:59 PM#63
Saving this for reference. Quality thread.
Last edited: Nov 11, 2023 at 8:59 PM
27 22wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 24 others
Reply Quote Save Share Report
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsNov 11, 2023 at 3:16 PM#64
Want to share my personal experience related to VERIFIED Vendor application since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 247 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 12 months later: I am down 67 lbs, my labs have normalized, and I am off 2 of my 3 medications. The VERIFIED Vendor aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
29 21ricardo_MIA, BrianDallas92, labquiet_amy and 26 others
Reply Quote Save Share Report
Nov 11, 2023 at 3:33 PM#65
Relevant to VERIFIED Vendor application — here is my latest bloodwork comparison:
Key improvements: A1C 8.4% → 5.5%, triglycerides 193 → 93 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Last edited: Nov 11, 2023 at 5:33 PM
2 5tampaLisa73, KarenAZ_mom
Reply Quote Save Share Report